Corvus Pharmaceuticals, Inc. CRVS
11.47 USD +0.10 (+0.88%)
At closeNov 11, 2026, 4:01 PM EST
11.47 0.00 0.00%
After hours · Nov 11, 4:01 PM ET
11.25 Day range 11.76
6.39 52-week range 26.95
- YTD
- +48.96%
- 1 year
- +40.39%
News
seekingalpha.com Corvus Pharmaceuticals: Durability, Not Peak Efficacy, Is The Real Product Corvus Pharmaceuticals offers a catalyst-rich, fully funded pipeline, highlighted by soquelitinib's potential for durable remission in atopic dermatitis and PTCL. Soquelitinib's post-treatment…
seekingalpha.com Corvus: 'Strong Buy' On Continued Soquelitinib Advancement And HS Data 1st Half 2027 Corvus Pharmaceuticals maintains a "Strong Buy" rating, driven by soquelitinib's advancing clinical programs in r/r PTCL and autoimmune indications. The phase 3 trial for relapsed/refractory PTCL…
globenewswire.com Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference in London SOUTH SAN FRANCISCO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership…
seekingalpha.com Corvus Pharmaceuticals, Inc. (CRVS) Q3 2026 Earnings Call Transcript Corvus Pharmaceuticals, Inc. (CRVS) Q3 2026 Earnings Call Transcript
marketbeat.com What Corvus Pharmaceuticals (CRVS) Said on Its Q3 Earnings Call Corvus Pharmaceuticals NASDAQ: CRVS reported a wider third-quarter loss as spending on clinical trials increased, while executives outlined a series of 2027 milestones for its lead experimental drug,…
benzinga.com Corvus Pharma Q3 2026 Earnings Call Transcript Corvus Pharma (NASDAQ:CRVS) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Corvus Pharma Q3 EPS $(0.22), Inline Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.22) per share which met the analyst consensus estimate. This is a 83.33 percent decrease over losses of $(0.12) per share from the same…
globenewswire.com Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hematology Annual Meeting & Exposition Data shows positive one-year safety and efficacy data from three patients enrolled in ongoing Phase 2 clinical trial being led by researchers at the National Institute of Allergy and Infectious…
benzinga.com Corvus Pharma Q2 2026 Earnings Call Transcript Corvus Pharma (NASDAQ:CRVS) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought…
benzinga.com Corvus Pharmaceuticals Starts Enrollment In Its Phase 1b Clinical Study Of Soquelitinib To Treat Hidradenitis Suppurativa Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that enrollment has begun in its Phase 1b clinical trial of soquelitinib for the treatment of…
benzinga.com Corvus Pharma Q2 EPS $(0.19) Misses $(0.17) Estimate Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 90 percent decrease over losses of…
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Crude Oil Tumbles 12%; State Street Posts Upbeat Earnings Stocks traded higher with Dow Jones up by 1,000 points. Consumer discretionary shares rose while energy stocks fell. State Street Corp reported upbeat earnings.
benzinga.com Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday The Dow Jones index rose 700 points, Autoliv Inc (NYSE: ALV) reported strong results causing a jump in its shares by 8.4% to $120.77. Other big gainers included CRML, ABTC, MFI, BYND, RXT, SHMD,…
benzinga.com This Woodward Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Earnings Scheduled For March 12, 2026 
benzinga.com Revolution Medicines, Erasca And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session 
benzinga.com Crude Oil Gains 2%; D.R. Horton Earnings Top Views 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Corvus Pharmaceuticals, Immunitybio, Acadia Healthcare And Other Big Stocks Moving Higher On Tuesday - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Earnings Scheduled For November 4, 2025 
benzinga.com Earnings Scheduled For August 7, 2025 - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com Earnings Scheduled For May 8, 2025
- benzinga.com Earnings Scheduled For March 25, 2025
benzinga.com This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
- benzinga.com Earnings Scheduled For November 12, 2024
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - benzinga.com Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- benzinga.com Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are…
- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
benzinga.com Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking…- benzinga.com Earnings Scheduled For August 8, 2023 Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.48 billion.
- benzinga.com Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.
- benzinga.com Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers
- benzinga.com Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.